Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
NXG NextGen Infrastructure Income Fund	NXG	18. nov 2024	47.03	+0.19
NXP Semiconductors	NXPI	18. nov 2024	220.19	+1.45
Nxu	NXU	18. nov 2024	0.29	-12.27
NYLI CBRE Global Infrastructure Megatrends Term Fund	MEGI	18. nov 2024	13.42	+0.30
NYSE Arca Biotech Index First Trust	FBT	18. nov 2024	161.85	+0.12
Nyse Composite	NYA	18. nov 2024	19 713.00	+0.42
Nyxoah SA	NYXH	18. nov 2024	8.18	-0.49
O-I Glass	OI	18. nov 2024	12.43	-4.16
Oak Valley Bancorp	OVLY	18. nov 2024	29.65	-0.67
Oak Woods Acquisition	OAKU	18. nov 2024	11.36	+0.09
Oaktree Acquisition III Life Sciences Unit	OACCU	18. nov 2024	10.03	0.00
Oaktree Capital A Pref	OAK-A	18. nov 2024	23.45	-0.17
Oaktree Capital Group B Pref	OAK-B	18. nov 2024	22.68	-0.18
Oaktree Specialty	OCSL	18. nov 2024	16.15	+0.75
Oatly ADR	OTLY	18. nov 2024	0.65	+6.52
Oblong	OBLG	18. nov 2024	2.97	-21.22
Occidental Petroleum	OXY	18. nov 2024	50.91	+1.88
Ocean Biomedical	OCEA	18. nov 2024	0.67	-6.86
Ocean Power Technologies	OPTT	18. nov 2024	0.15	+7.00
Oceaneering International	OII	18. nov 2024	27.46	+2.42
OceanFirst Financial	OCFC	18. nov 2024	20.32	-0.83
OceanFirst Pref	OCFCP	18. nov 2024	25.10	-0.96
OceanPal	OP	18. nov 2024	1.47	+1.02
Ocugen	OCGN	18. nov 2024	0.91	-2.92
Ocular Therapeutix	OCUL	18. nov 2024	8.69	-5.13
Oculis	OCS	18. nov 2024	14.62	+3.39
Ocuphire Pharma	OCUP	18. nov 2024	1.17	0.00
Oddity Tech	ODD	18. nov 2024	39.71	-0.10
Odyssey Marine Exploration	OMEX	18. nov 2024	0.41	+3.85
Offerpad Solutions A	OPAD	18. nov 2024	3.62	-2.43

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.